The US hospital emergency department market was estimated at US$ 156 billion in 2022 and expected to hit US$ 265.20 billion by 2032, expanding growth at a CAGR of 5.50% over the forecast period 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The rising number of hospital emergency department visits in the US is the primary driver of the US hospital emergency department market. According to the Centers for Disease Control and Prevention (CDC), there were around 130 million emergency department visits in US in 2018. The injury related visits accounted for 35 million. Moreover, the maximum number emergency care services were provided during the non-business hours. The high costs associated with the emergency care services in US has resulted in the increased revenue growth of the hospital emergency department market. The rising prevalence of various chronic diseases and growing geriatric population are the most prominent factors that drives the growth of the US hospital emergency department market. According to the National Center for Health Statistics, heart diseases were the leading cause of death in US that accounted for 690,882 deaths in 2020, followed by the cancer (598,932 deaths), and accidents & injuries (192,176 deaths). Furthermore, there were over 46 million geriatric people of age 65 years and above in the US in 2020 and this number is expected to reach at around 90 million by 2050. The old age people are prone to various diseases and have higher chances of acquiring emergency care services.
| Report Coverage | Details |
| Market Size | US$ 265.20 Billion by 2032 |
| Growth Rate from 2023 to 2032 | CAGR of 5.50% |
| By Insurance |
|
| By Health Condition |
|
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Insurance, Health Condition, Region |
| Companies Mentioned | Albany Molecular Research Inc., EVOTEC, Laboratory Corporation of America Holdings, GenScript, Pharmaceutical Product Development, LLC., Charles River, WuXiAppTec, Merck & Co., Inc., Thermo Fisher Scientific Inc., Dalton Pharma Services, Oncodesign, Jubilant Biosys, DiscoverX Corporation, and QIAGEN |
The rising adoption of the digital technologies like telehealth and integration of telehealth with the latest technologies like artificial intelligence, internet of things, blockchain, cloud computing, and big data is estimated to be the future of the US healthcare industry. The rising government initiatives to boost the deployment of the digital and advanced technologies in hospitals are expected to significantly drive the growth of the US hospital emergency department market in the forthcoming years. Furthermore, the increased penetration of the healthcare insurances among the US population has favored the growth of the market. Most of the people depends on the reimbursements for receiving treatment. The insurance companies play a significant role in the growing healthcare expenditure in the economy. Moreover, the increasing adoption of the telemedicine has forced the government to introduce appropriate changes in the policies to cover the telehealth related expenses in US. Furthermore, the increased government expenditure on the healthcare infrastructure building is positively impacting the market growth. It is estimated that US spends more than 17% of its GDP on healthcare expenditure. Therefore, the presence of strong healthcare infrastructure in US plays a prominent role in the growth of the US hospital emergency department market.
The outbreak of the COVID-19 pandemic in 2022 has adversely affected the US economy and collapsed the whole US healthcare infrastructure. The rapid spread of the COVID-19 disease among the US population resulted in the increased number of emergency department visits in 2020. According to the National Center for Health Statistics, the COVID-19 diseases resulted in around 598,932 deaths in US in 2020. The demand for the emergency care services suddenly witnessed a huge spike during the pandemic and the lack of the proper reimbursement policies for this new disease had negatively impacted the US hospital emergency department market to some extent. However, the introduction of vaccines and rapid vaccination roll outs in US is expected to bring down the situation under control by 2021. The COVID-19 situation has shifted the governments focus towards the development of the telehealth infrastructure to extend the virtual healthcare services to the population that would decreases the pressure on the hospital emergency departments. Therefore, the active government role in the development of hospital infrastructure is expected to drive the growth of the US hospital emergency department market in the forthcoming years.
Based on the health condition, the infectious segment accounted for over 38% of the market share and dominated the US hospital emergency department market in 2020. This segment is also expected to be the fastest-growing during the forecast period. The rising prevalence of various infectious diseases such as influenza, viral hepatitis, measles, sexually transmitted diseases (STDs), and pneumonia, which results in the surging number of emergency department visits in US is expected to drive the market growth in the forthcoming years. Furthermore, the rising prevalence of cancer, cardiovascular diseases, and respiratory diseases has increased the chances of the emergency department visits. Therefore, the growing prevalence of various non-communicable diseases coupled with the rising geriatric population is estimated to have a significant impact on the market growth during the forecast period.
The traumatic segment held the second leading position in the US hospital emergency department market in 2020. This is due to the increased number of traumatic cases in the US. According to the US CDC, around 192,176 deaths were recorded due to accidents and injuries in 2020. This number has increased by around 31.1% since 2015. Therefore, the rapid increase in these cases has resulted in the rapid growth of this segment.
Based on the insurance, the private segment dominated the US hospital emergency department market and garnered a market share of over 52% in 2020. The private insurance companies offer more advantages to the customers as compared to that of the Medicare/Medicaid. Therefore, the increased adoption of the private healthcare insurance policies has fostered the growth of the US hospital department market significantly in the past. Furthermore, the extra services and facilities provided by the private insurance companies during the emergency visits has propelled the growth of this segment.
On the other hand, the Medicare/Medicaid is estimated to be the fastest-growing segment during the forecast period. The appropriate government regulations have resulted in the improved reimbursement policies. Furthermore, the favorable regulatory changes for the reimbursement of payments related to the telehealth services is expected to foster the adoption of the Medicare/Medicaid segment in US hospital emergency department market in the forthcoming years.
Key Market Developments
The US hospital emergency department market is highly fragmented with the presence of numerous local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improved products. Moreover, they are also focusing on maintaining competitive pricing.
Segments Covered in the Report
By Health Condition
By Insurance
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
